Quantitative Analysis of 18F-Fluorodeoxyglucose Positron Emission Tomography Identifies Novel Prognostic Imaging Biomarkers in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy

International Journal of Radiation Oncology Biology Physics

Volumn 96, Issue 1, 2016, Pages 102-109

  Cui, Yi ^a,b   Song, Jie ^a   Pollom, Erqi ^a   Alagappan, Muthuraman ^a   Shirato, Hiroki ^b   Chang, Daniel T ^a,c   Koong, Albert C ^a,c   Li, Ruijiang ^a,b,c  

^a STANFORD UNIVERSITY   (United States)

^b HOKKAIDO UNIVERSITY   (Japan)

^c STANFORD CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMARKERS; DISEASES; ELECTRONS; HAZARDS; IMAGE ANALYSIS; MULTIVARIANT ANALYSIS; PATIENT MONITORING; PATIENT TREATMENT; POSITRONS; RADIOTHERAPY; REGRESSION ANALYSIS; TUMORS;

18-F-FLUORODEOXYGLUCOSE; COX REGRESSION ANALYSIS; INSTITUTIONAL REVIEW BOARDS; LOCALLY ADVANCED PANCREATIC CANCERS; MAXIMUM STANDARDIZED UPTAKE VALUES; MULTI VARIATE ANALYSIS; QUANTITATIVE IMAGE ANALYSIS; STEREOTACTIC BODY RADIATION THERAPY;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18; BIOLOGICAL MARKER; RADIOPHARMACEUTICAL AGENT;

ADULT; AGE; AGED; ARTICLE; CANCER PATIENT; COHORT ANALYSIS; CYBERKNIFE; FEMALE; GLYCOLYSIS; HIGH RISK POPULATION; HUMAN; IMAGE ANALYSIS; LINEAR ACCELERATOR; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS CANCER; PET-CT SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL PREDICTION; TUMOR VOLUME; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; MIDDLE AGED; MORTALITY; PANCREATIC NEOPLASMS; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RADIOSURGERY; RADIOTHERAPY DOSAGE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ADULT; AGED; BIOMARKERS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOPHARMACEUTICALS; RADIOSURGERY; RADIOTHERAPY DOSAGE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84990818423     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2016.04.034     Document Type: Article

References (41)

1. 1 Siegel, R., Ma, J., Zou, Z., et al. Cancer statistics, 2014. CA Cancer J Clin 64 (2014), 9–29.
2. 2 Yeo, C.J., Cameron, J.L., Lillemoe, K.D., et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 221 (1995), 721–731 [discussion 731-733].
3. 3 Sener, S.F., Fremgen, A., Menck, H.R., et al. Pancreatic cancer: A report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 189 (1999), 1–7.
4. 4 Sahani, D.V., Bonaffini, P.A., Catalano, O.A., et al. State-of-the-art PET/CT of the pancreas: Current role and emerging indications. Radiographics 32 (2012), 1133–1158 [discussion 1158-1160].
5. 5 Okamoto, K., Koyama, I., Miyazawa, M., et al. Preoperative 18[F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts early recurrence after pancreatic cancer resection. Int J Clin Oncol 16 (2011), 39–44.
6. 6 Hwang, J.P., Lim, I., Chang, K.J., et al. Prognostic value of SUVmax measured by fluorine-18 fluorodeoxyglucose positron emission tomography with computed tomography in patients with pancreatic cancer. Nucl Med Mol Imaging 46 (2012), 207–214.
7. 7 Yamamoto, T., Sugiura, T., Mizuno, T., et al. Preoperative FDG-PET predicts early recurrence and a poor prognosis after resection of pancreatic adenocarcinoma. Ann Surg Oncol 22 (2015), 677–684.
8. 8 Schellenberg, D., Quon, A., Minn, A.Y., et al. 18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 77 (2010), 1420–1425.
9. 9 Lee, J.W., Kang, C.M., Choi, H.J., et al. Prognostic value of metabolic tumor volume and total lesion glycolysis on preoperative 18F-FDG PET/CT in patients with pancreatic cancer. J Nucl Med 55 (2014), 898–904.
10. 10 Dholakia, A.S., Chaudhry, M., Leal, J.P., et al. Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 89 (2014), 539–546.
11. 11 Kumar, V., Gu, Y., Basu, S., et al. Radiomics: The process and the challenges. Magn Reson Imaging 30 (2012), 1234–1248.
12. 12 Lambin, P., Rios-Velazquez, E., Leijenaar, R., et al. Radiomics: Extracting more information from medical images using advanced feature analysis. Eur J Cancer 48 (2012), 441–446.
13. 13 Lu, W., Wang, J., Zhang, H.H., Computerized PET/CT image analysis in the evaluation of tumour response to therapy. Br J Radiol, 88, 2015, 20140625.
14. 14 Jia, Wu, Todd, Aguilera, David, Shultz, et al. Early-stage non-small cell lung cancer: Quantitative imaging characteristics of 18F fluorodeoxyglucose PET/CT allow prediction of distant metastasis. Radiology, 2016, 151829.
15. 15 Aerts, H.J., Velazquez, E.R., Leijenaar, R.T., et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun, 5, 2014, 4006.
16. 16 Hatt, M., Majdoub, M., Vallières, M., et al. 18F-FDG PET uptake characterization through texture analysis: Investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort. J Nucl Med 56 (2015), 38–44.
17. 17 Leijenaar, R.T., Carvalho, S., Hoebers, F.J., et al. External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma. Acta Oncol 54 (2015), 1423–1429.
18. 18 Cui, Y., Tha, K.K., Terasaka, S., et al. Prognostic imaging biomarkers in glioblastoma: Development and independent validation on the basis of multiregion and quantitative analysis of MR images. Radiology 278 (2016), 546–553.
19. 19 Tixier, F., Le Rest, C.C., Hatt, M., et al. Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer. J Nucl Med 52 (2011), 369–378.
20. 20 ACR-AAPM Technical Standard for Medical Physics Performance Monitoring of PET/CT Imaging Equipment. Available at: www.acr.org/∼/media/5A6923DBCB254D8F9E29D082C1B28E79.pdf. Accessed March 23, 2016.
21. 21 Klein, S., Staring, M., Murphy, K., et al. elastix: A toolbox for intensity-based medical image registration. IEEE Trans Med Imaging 29 (2010), 196–205.
22. 22 Shrout, P.E., Fleiss, J.L., Intraclass correlations: Uses in assessing rater reliability. Psychol Bull 86 (1979), 420–428.
23. 23 Leijenaar, R.T., Carvalho, S., Velazquez, E.R., et al. Stability of FDG-PET radiomics features: An integrated analysis of test-retest and inter-observer variability. Acta Oncol 52 (2013), 1391–1397.
24. 24 Simon, N., Friedman, J., Hastie, T., et al. Regularization paths for Cox's proportional hazards model via coordinate descent. J Stat Softw 39 (2011), 1–13.
25. 25 Tibshirani, R., The lasso method for variable selection in the Cox model. Stat Med 16 (1997), 385–395.
26. 26 Harrell, F.E., Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. 2001, Springer Science & Business Media, New York.
27. 27 Cheng, W.Y., Ou Yang, T.H., Anastassiou, D., Development of a prognostic model for breast cancer survival in an open challenge environment. Sci Transl Med, 5, 2013, 181ra50.
28. 28 Simon, R.M., Subramanian, J., Li, M.C., et al. Using cross-validation to evaluate predictive accuracy of survival risk classifiers based on high-dimensional data. Brief Bioinform 12 (2011), 203–214.
29. 18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 77 (2010), 1420–1425.
30. 30 Tixier, F., Hatt, M., Valla, C., et al. Visual versus quantitative assessment of intratumor 18F-FDG PET uptake heterogeneity: Prognostic value in non-small cell lung cancer. J Nucl Med 55 (2014), 1235–1241.
31. 31 Cook, G.J., Yip, C., Siddique, M., et al. Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy?. J Nucl Med 54 (2013), 19–26.
32. 32 Cook, G.J., O'Brien, M.E., Siddique, M., et al. Non-small cell lung cancer treated with erlotinib: Heterogeneity of (18)F-FDG uptake at PET—association with treatment response and prognosis. Radiology 276 (2015), 883–893.
33. 33 Vallières, M., Freeman, C.R., Skamene, S.R., et al. A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities. Phys Med Biol 60 (2015), 5471–5496.
34. 34 El Naqa, I., Grigsby, P., Apte, A., et al. Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. Pattern Recognit 42 (2009), 1162–1171.
35. 35 Klaassen, R., Bennink, R.J., van Tienhoven, G., et al. Feasibility and repeatability of PET with the hypoxia tracer [(18)F]HX4 in oesophageal and pancreatic cancer. Radiother Oncol 116 (2015), 94–99.
36. 36 Beals M, Gross LJ, Harrell S. Sizes of Organisms: The Surface Area:Volume Ratio. Available at: www.tiem.utk.edu/∼gross/bioed/bealsmodules/area_volume.html. Accessed March 24, 2016.
37. 37 Saad, E.D., Machado, M.C., Wajsbrot, D., et al. Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine. Int J Gastrointest Cancer 32 (2002), 35–41.
38. 38 Brooks, F.J., Grigsby, P.W., The effect of small tumor volumes on studies of intratumoral heterogeneity of tracer uptake. J Nucl Med 55 (2014), 37–42.
39. 39 Zhang, H., Tan, S., Chen, W., et al. Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics. Int J Radiat Oncol Biol Phys 88 (2014), 195–203.
40. 40 Nehmeh, S.A., Erdi, Y.E., Pan, T., et al. Four-dimensional (4D) PET/CT imaging of the thorax. Med Phys 31 (2004), 3179–3186.
41. 41 Nair, V.S., Gevaert, O., Davidzon, G., et al. Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer. Cancer Res 72 (2012), 3725–3734.